Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
评价伊潘立酮片治疗精神分裂症的有效性和安全性
CTR20160170Phase 2Active
- Sponsor
- Tianjin Hankang Pharmaceutical Biotechnology
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iloperidone in schizophrenia, sponsored by Tianjin Hankang Pharmaceutical Biotechnology. Started Apr 2016; status: active.
02
Drugs
iloperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20160170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160170.